Dimitri LeggasMuthu Manikandan BaskaranJames EzickBrendan von Hofe
Drug repositioning (also called "drug repurposing") is a drug development strategy that saves time and money by finding new uses for existing drugs. While a variety of computational approaches to drug repositioning exist, recent work has shown that tensor decomposition, an unsupervised learning technique for finding latent structure in multidimensional data, is a useful tool for drug repositioning. The known relationships between drugs, targets, and diseases can easily be encoded as a tensor, and by learning a low-rank representation of this tensor, decompositions can complete missing entries and therefore predict novel drug-disease associations. Multiple recent works, in the context of cancer and COVID-19 drug discovery, have used joint tensor decompositions to suggest drug repositioning candidates. While these methods make high-quality predictions, they rely on specialized decompositions formulated for specific problems. In this work, we use ENSIGN, a suite of tensor decomposition tools, to show that CP tensor decompositions of a single tensor encoding drug-target-disease associations are capable of predicting verifiable drug repositioning candidates. Because the tensors generated by drug repositioning problems are sparse, we introduce a filtered tensor construction to limit the span of the tensor without losing information needed to learn the relevant associations. We show that our method predicts verifiable novel drug-disease associations in cancer and COVID-19 data. The simplicity of our approach makes it an attractive tool for biomedical researchers looking for out-of-the-box solutions, and ENSIGN brings an added level of usability and scalability.
Ali Akbar JamaliYuting TanAnthony KusalikFang‐Xiang Wu
Ran WangShuai LiMan Hon WongKwong‐Sak Leung
Ran WangShuai LiLixin ChengMan Hon WongKwong‐Sak Leung